Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecules and Cells

• Publication date

  2015-06-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.molcel.2015.05.007PMID 26091342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Processing of protein ADP-ribosylation by Nudix hydrolases.

  2015cited by this paper
• Synthesis of dimeric ADP-ribose and its structure with human poly(ADP-ribose) glycohydrolase.

  2015cited by this paper
• PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1

  2014cited by this paper
• Crystallographic and Biochemical Analysis of the Mouse Poly(ADP-Ribose) Glycohydrolase

  2014cited by this paper
• Conformational Activation of Poly(ADP-ribose) Polymerase-1 upon DNA Binding Revealed by Small-Angle X-ray Scattering

  2014cited by this paper
• Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response

  2014cited by this paper
• Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life

  2014cited by this paper
• PARP12, an Interferon-stimulated Gene Involved in the Control of Protein Translation and Inflammation*

  2014cited by this paper
• Family-wide analysis of poly(ADP-ribose) polymerase activity

  2014cited by this paper
• The oligonucleotide/oligosaccharide-binding fold motif is a poly(ADP-ribose)-binding domain that mediates DNA damage response

  2014cited by this paper
• Structural Implications for Selective Targeting of PARPs

  2013cited by this paper
• Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10

  2013cited by this paper
• Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease

  2013cited by this paper
• PARP inhibitors in cancer therapy: an update

  2013cited by this paper
• A family of macrodomain proteins reverses cellular mono-ADP-ribosylation

  2013cited by this paper
• ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress

  2013cited by this paper
• Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation

  2013cited by this paper
• Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8 macrodomains.

  2013cited by this paper
• Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases

  2013cited by this paper
• The recognition and removal of cellular poly(ADP‐ribose) signals

  2013cited by this paper
• Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome

  2013cited by this paper
• Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities

  2013cited by this paper
• PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis.

  2013cited by this paper
• Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling

  2013cited by this paper
• Visualization of a DNA-PK/PARP1 complex

  2012cited by this paper
• PARP16/ARTD15 Is a Novel Endoplasmic-Reticulum-Associated Mono-ADP-Ribosyltransferase That Interacts with, and Modifies Karyopherin-ß1

  2012cited by this paper
• PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK and IRE1α-mediated unfolded protein response

  2012cited by this paper
• Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives

  2012cited by this paper
• Reprogramming cellular events by poly(ADP-ribose)-binding proteins

  2012cited by this paper
• Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination.

  2012cited by this paper
• Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

  2012cited by this paper
• Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1

  2012cited by this paper
• The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks

  2012cited by this paper
• Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase

  2012cited by this paper
• Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a unique substrate-binding element

  2012cited by this paper
• Crystal Structure of Human ADP-ribose Transferase ARTD15/PARP16 Reveals a Novel Putative Regulatory Domain*

  2012cited by this paper
• New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

  2012cited by this paper
• Structural insight into the interaction of ADP‐ribose with the PARP WWE domains

  2012cited by this paper
• The DNA-Binding Domain of Human PARP-1 Interacts with DNA Single-Strand Breaks as a Monomer through Its Second Zinc Finger

  2011cited by this paper
• Orphan Macrodomain Protein (Human C6orf130) Is an O-Acyl-ADP-ribose Deacylase

  2011cited by this paper
• PARP-3 and APLF function together to accelerate nonhomologous end-joining.

  2011cited by this paper
• The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase

  2011cited by this paper
• DNA repair factor APLF is a histone chaperone.

  2011cited by this paper
• Identification of Macrodomain Proteins as Novel O-Acetyl-ADP-ribose Deacetylases*

  2011cited by this paper
• Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA

  2011cited by this paper
• Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.

  2011cited by this paper
• Solution structures of the two PBZ domains from human APLF and their interaction with poly(ADP-ribose)

  2010cited by this paper
• The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction*

  2010cited by this paper
• Toward a unified nomenclature for mammalian ADP-ribosyltransferases.

  2010cited by this paper
• Identification of a regulatory segment of poly(ADP-ribose) glycohydrolase.

  2010cited by this paper
• A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation

  2009cited by this paper
• Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites

  2009cited by this paper
• Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

  2009cited by this paper
• Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1

  2009cited by this paper
• Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential.

  2009cited by this paper
• Mechanism of ADP-ribosylation removal revealed by the structure and ligand complexes of the dimanganese mono-ADP-ribosylhydrolase DraG

  2009cited by this paper
• Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins

  2008cited by this paper
• Differential Activities of Cellular and Viral Macro Domain Proteins in Binding of ADP-Ribose Metabolites

  2008cited by this paper
• Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.

  2008cited by this paper
• The single-macro domain protein LRP16 is an essential cofactor of androgen receptor.

  2008cited by this paper
• DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation.

  2007cited by this paper
• Poly(ADP-ribose) Accumulation and Enhancement of Postischemic Brain Damage in 110-kDa Poly(ADP-ribose) Glycohydrolase Null Mice

  2006cited by this paper
• Poly(ADP-ribose) (PAR) polymer is a death signal

  2006cited by this paper
• Identification and Characterization of a Mammalian 39-kDa Poly(ADP-ribose) Glycohydrolase*

  2006cited by this paper
• The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation

  2006cited by this paper
• Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor.

  2006cited by this paper
• A highly specific phosphatase that acts on ADP-ribose 1″-phosphate, a metabolite of tRNA splicing in Saccharomyces cerevisiae

  2005cited by this paper
• Identification of three critical acidic residues of poly(ADP-ribose) glycohydrolase involved in catalysis: determining the PARG catalytic domain.

  2005cited by this paper
• Splicing regulates NAD metabolite binding to histone macroH2A

  2005cited by this paper
• PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation

  2005cited by this paper
• B-aggressive Lymphoma Family Proteins Have Unique Domains That Modulate Transcription and Exhibit Poly(ADP-ribose) Polymerase Activity*

  2005cited by this paper
• The Zinc Finger Antiviral Protein Directly Binds to Specific Viral mRNAs through the CCCH Zinc Finger Motifs

  2004cited by this paper
• Poly(ADP-ribose) is required for spindle assembly and structure

  2004cited by this paper
• Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality.

  2004cited by this paper
• The macro domain is an ADP‐ribose binding module

  2004cited by this paper
• Functional interaction between PARP‐1 and PARP‐2 in chromosome stability and embryonic development in mouse

  2003cited by this paper
• Inhibition of Retroviral RNA Production by ZAP, a CCCH-Type Zinc Finger Protein

  2002cited by this paper
• The WWE domain: a common interaction module in protein ubiquitination and ADP ribosylation.

  2001cited by this paper
• Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

  1999cited by this paper
• The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase

  1999cited by this paper
• The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.

  1998cited by this paper
• Isolation and Characterization of the cDNA Encoding Bovine Poly(ADP-ribose) Glycohydrolase*

  1997cited by this paper
• Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching.

  1997cited by this paper
• Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

  1996cited by this paper
• Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.

  1996cited by this paper
• Characterisation of a gain-of-function mutant of poly(ADP-ribose) polymerase.

  1995cited by this paper
• Characterization of a Gain-of-Function Mutant of Poly(ADP-Ribose) Polymerase

  1995cited by this paper
• Role of Glutamic Acid 988 of Human Poly-ADP-ribose Polymerase in Polymer Formation

  1995cited by this paper
• Glycation of proteins by ADP-ribose

  1994cited by this paper
• Endoglycosidic cleavage of branched polymers by poly(ADP-ribose) glycohydrolase.

  1994cited by this paper
• Mode of action of poly(ADP-ribose) glycohydrolase.

  1994cited by this paper
• MacroH2A, a core histone containing a large nonhistone region.

  1992cited by this paper
• The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA.

  1990cited by this paper
• ADP-ribosyl protein lyase. Purification, properties, and identification of the product.

  1984cited by this paper
• Glutamyl ribose 5-phosphate storage disease. A hereditary defect in the degradation of poly(ADP-ribosylated) proteins.

  1984cited by this paper
• Poly(ADP-ribose) has a branched structure in vivo.

  1982cited by this paper
• DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins.

  1982cited by this paper
• Structure of poly(adenosine diphosphate ribose): identification of 2'-[1''-ribosyl-2''-(or 3''-)(1'''-ribosyl)]adenosine-5',5'',5'''-tris(phosphate) as a branch linkage.

  1979cited by this paper
• Poly ADP-ribose glycohydrolase from rat liver nuclei, a novel enzyme degrading the polymer.

  1972cited by this paper
• Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-robose) by a calf thymus extract.

  1971cited by this paper

• Poly (ADP-ribose) polymerase inhibitors in cancer therapy

  2025cites this paper
• PARP inhibitors in ovarian cancer: Mechanisms of resistance and implications to therapy.

  2025cites this paper
• Combination Therapy Using Phytochemicals and PARP Inhibitors in Hybrid Nanocarriers: An Optimistic Approach for the Management of Colon Cancer

  2025cites this paper
• Prognostic Marker PARP11 in Head and Neck Squamous Cell Carcinoma and its Relationship with Immune Infiltration

  2025cites this paper
• Single-molecule analysis of PARP1-G-quadruplex interaction

  2025cites this paper
• Histone PARylation factor 1: a review of its role in the DNA damage response

  2025cites this paper
• GRAIN SIZE ON CHROMOSOME 2 orchestrates phytohormone, sugar signaling and energy metabolism to confer thermal resistance in rice

  2025cites this paper
• PARP7: an Emerging Therapeutic Target-Insights into Biological Functions and Advances in Small-Molecule Inhibitor Development.

  2025cites this paper
• Mechanistic insights into P-glycoprotein-driven transport of anti-cancer PARP inhibitors.

  2025cites this paper
• PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers.

  2025cites this paper
• Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage.

  2025cites this paper
• PARP enzyme synthesis of protein-free poly(ADP-ribose): Implications for DNA damage signaling and repair.

  2025cites this paper
• Parps in immune response: Potential targets for cancer immunotherapy.

  2025cites this paper
• Targeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer Therapies

  2025cites this paper
• RECQL4 requires PARP1 for recruitment to DNA damage, and PARG dePARylation facilitates its associated role in end joining

  2025cites this paper
• Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms

  2024cites this paper
• Exploration of novel 3-substituted indole derivatives through multicomponent reaction: In vitro cytotoxicity, in silico docking, and molecular dynamics

  2024cites this paper
• Covalent PARylation of DNA base excision repair proteins regulates DNA demethylation

  2024cites this paper
• Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer

  2024cites this paper
• PARP1 condensates differentially partition DNA repair proteins and enhance DNA ligation

  2024cites this paper
• Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15

  2024cites this paper
• Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.

  2024cites this paper
• Poly‐ADP‐ribosylation dynamics, signaling, and analysis

  2024cites this paper
• Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

  2024cites this paper
• ADP-ribose hydrolases: biological functions and potential therapeutic targets

  2024cites this paper
• Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms

  2024cites this paper
• Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader

  2024cites this paper
• Evaluation of the efficacy of marine natural products against PARP-1/2 proteins in high-grade serous ovarian cancer: insights into MD and SMD simulations

  2024influential citation
• PARP1 condensates differentially partition DNA repair proteins and enhance DNA ligation

  2024cites this paper
• The MACROD2 rs6110695 A>G Polymorphism and the Metabolites Indoleacrylic Acid and Butyrylcarnitine Potentially Have Clinical Relevance to WBC Count Prediction

  2024cites this paper
• The Stabilization Effect of Agmatine‐Salicylate Ionic Liquids on PARP‐1 for Parkinson's Disease: A Perspective from DFT and MD Simulations

  2024cites this paper
• Molecular mechanisms of cell death by parthanatos: More questions than answers

  2024cites this paper
• Crystal structure and biochemical activity of the macrodomain from rubella virus p150

  2024cites this paper
• Mechanism of PARP1 Elongation Reaction Revealed by Molecular Modeling

  2024cites this paper
• Small molecule inhibitors targeting heat shock protein 90: An updated review.

  2024cites this paper
• Novel anti-Acanthamoeba effects elicited by a repurposed poly (ADP-ribose) polymerase inhibitor AZ9482

  2024cites this paper
• ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombination

  2024cites this paper
• Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage

  2023cites this paper
• Efficacy and safety of PARP inhibitors for maintenance treatment of ovarian cancer, regardless of BRCA or HRD status: a comprehensive updated meta-analysis

  2023cites this paper
• PARP inhibitors combined with radiotherapy: are we ready?

  2023cites this paper
• PARP-nucleic acid interactions: Allosteric signaling, PARP inhibitor types, DNA bridges, and viral RNA surveillance.

  2023cites this paper
• Molecular basis for the reversible ADP-ribosylation of guanosine bases

  2023cites this paper
• Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation

  2023cites this paper
• DNA-PKcs-dependent resistance to PARP inhibitors in BRCA 1-mutated cancer cells

  2023cites this paper
• Crystal structure and biochemical activity of the macro domain from rubella virus p150

  2023cites this paper
• Updated protein domain annotation of the PARP protein family sheds new light on biological function

  2023cites this paper
• Combining Poly (ADP-Ribose) Polymerase (PARP) Inhibitors with Chemotherapeutic Agents: Promise and Challenges.

  2023cites this paper
• Identification of indole-based natural compounds as inhibitors of PARP-1 against triple-negative breast cancer: a computational study

  2023influential citation
• A Clickable NAD+ Analog-Based Assay of Poly(ADP-Ribosyl)ated Proteins.

  2023cites this paper
• ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification

  2023cites this paper
• The Complex Network of ADP-Ribosylation and DNA Repair: Emerging Insights and Implications for Cancer Therapy

  2023cites this paper
• Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma

  2023cites this paper
• PARP1-catalyzed PARylation of YY1 mediates endoplasmic reticulum stress in granulosa cells to determine primordial follicle activation

  2023cites this paper
• Regulation of Biomolecular Condensates by Poly(ADP-ribose).

  2023cites this paper
• DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids

  2023cites this paper
• Hypoxia-inducible factor-1α and poly [ADP ribose] polymerase 1 cooperatively regulate Notch3 expression under hypoxia via a noncanonical mechanism

  2022cites this paper
• ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives

  2022cites this paper
• PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites

  2022cites this paper
• Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer

  2022cites this paper
• Neuralized-like protein 4 (NEURL4) mediates ADP-ribosylation of mitochondrial proteins

  2022cites this paper
• Profiling of the ADP‐Ribosylome in Living Cells

  2022cites this paper
• Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology

  2022cites this paper
• The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1

  2022cites this paper
• Inhibitors of PARP: Number crunching and structure gazing

  2022cites this paper
• Role of PARP-1 in Human Cytomegalovirus Infection and Functional Partners Encoded by This Virus

  2022cites this paper
• Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis

  2022cites this paper
• The ADP-ribose hydrolase NUDT5 is important for DNA repair.

  2022cites this paper
• How cancer cells make and respond to interferon-I.

  2022cites this paper
• KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway

  2022cites this paper
• Loss of ZNF251 stimulates NHEJ resulting in PARP inhibitor resistance in BRCA1 mutated cancer cells

  2022cites this paper
• DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on protein substrates

  2022cites this paper
• Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling

  2021cites this paper
• Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers

  2021cites this paper
• Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins

  2021cites this paper
• ADP-ribosylhydrolases: from DNA damage repair to COVID-19

  2021cites this paper
• Structural and Functional Characterization of Legionella pneumophila Effector MavL

  2021cites this paper
• The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance.

  2021cites this paper
• Stress granule formation, disassembly, and composition are regulated by alphavirus ADP-ribosylhydrolase activity

  2021cites this paper
• Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration.

  2021cites this paper
• Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.

  2021cites this paper
• PARP1-modulated chromatin remodeling is a new target for cancer treatment

  2021cites this paper
• Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose)

  2021cites this paper
• Molecular basis for DarT ADP-ribosylation of a DNA base

  2021cites this paper
• Dictyostelium discoideum as a Model to Assess Genome Stability Through DNA Repair

  2021cites this paper
• PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair

  2021cites this paper
• Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?

  2021cites this paper
• Detecting ADP-Ribosylation in RNA.

  2021cites this paper
• First body of evidence suggesting a role of a tankyrase-binding motif (TBM) of vinculin (VCL) in epithelial cells

  2021cites this paper
• PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling

  2021cites this paper
• The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials

  2021cites this paper
• ADP-ribosylation of DNA and RNA

  2021cites this paper
• Identification of poly(ADP-ribose)polymerase 1 and 2 (PARP1/2) as targets of andrographolide using an integrated chemical biology approach.

  2021cites this paper
• ADP-ribosylation systems in bacteria and viruses

  2021cites this paper
• TARG1 protects against toxic DNA ADP-ribosylation

  2021cites this paper
• Functional Roles of PARP2 in Assembling Protein–Protein Complexes Involved in Base Excision DNA Repair

  2021cites this paper
• Systematic comparison of ligand-based and structure-based virtual screening methods on poly (ADP-ribose) polymerase-1 inhibitors

  2021cites this paper
• Structural and biochemical analysis of human ADP-ribosyl-acceptor hydrolase 3 reveals the basis of metal selectivity and different roles for the two magnesium ions

  2021cites this paper
• Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises.

  2021cites this paper
• The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies

  2021cites this paper
• PARP1: Structural insights and pharmacological targets for inhibition.

  2021cites this paper